“…Results using allogeneic telomerase negative MSCs, expressing MHC Class-I on their cell surfaces, demonstrated either stasis of disease progression, slowed disease progression, or no effect on disease progression with MSC transplantation [7,8,50,51,55,60,61,[64][65][66][67][68][69][70][71][72][73][74][75][76]90,92,95,96,99,103,106,107,[149][150][151]. These studies suggested that there was an immunomodulatory rather than a reparative effect of the MSCs with respect to the diseases treated.…”